Breaking News

Aurigene Expands Biologics CDMO Capacity

Invests $40 million in an R&D and pilot scale facility at a biotechnology park in Hyderabad.

Aurigene Pharmaceutical Services Limited, a contract research, development, and manufacturing services organization (CDMO) and a step-down subsidiary of Dr. Reddy’s Laboratories announced the construction of a state-of-the art development and manufacturing facility for therapeutic proteins, antibodies, and viral vectors. The building is expected to be fully operational in first half of 2024. As a first step, Aurigene is investing $40 million in an R&D and pilot scale facility at Gen...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters